Pharmaceuticals Market Research Reports & Industry Analysis
The global pharmaceutical industry is a vital part of the healthcare landscape—affecting everyone, from patients seeking treatment to healthcare providers looking for the latest advances in medicine. That's why MarketResearch.com offers a wide range of pharmaceutical reports, providing critical insights into market trends, industry challenges, and emerging opportunities.
What’s Inside Our Pharmaceutical Industry Reports
- We cover an extensive range of segments within the pharmaceutical industry, including biopharmaceuticals, clinical trials, dietary supplements, drug discovery, manufacturing & packaging, over-the-counter drugs, prescription drugs, research & development, vaccines, and more.
- Our research offers valuable information on the market landscape, key factors driving change, company and product profiles, and regulatory analysis.
- We also cover disruptive trends, such as gene editing, precision medicine, and artificial intelligence, ensuring our clients stay ahead of market changes.
MarketResearch.com: A Reliable Source for Critical Data
At MarketResearch.com, we understand the importance of reliable and comprehensive research. For over 20 years, we have been a leading company in the field of market research, bringing together reports from hundreds of leading firms in one place for convenient access.
View recent articles on this industry on our blog:
4 Blockbuster Drugs to Watch for Non-Small Lung Cancer (NSCLC)
Global Prefilled Syringes Market to Achieve Unprecedented Growth by 2035
Global Medical Aesthetic Market to Surge to $102.2 Billion by 2035
Cancer Biomarker Market Size to Reach $39.7 Billion by 2028
Additional articles on this industry
Pharmaceuticals Industry Research & Market Reports
-
Drug Abuse Testing Market Report By Drug Type (Opioids, Cocaine, Alcohol, Cannabis/Marijauna, Amphetamine & Methaphetamine, LSD, Others), Product & Services (Consumables, Analysers, Rapid Testing Devices, Laboratory Services), Sample Type (Breath, Hair, Urine, Oral Fluid, Others), End Users (Rehabilitation Centers, Drug Testing Laboratories, Workplaces, Hospitals, Academic Institutes and Research Centers, Others) Countries and Company Analysis 2024-2032
... End Users (Rehabilitation Centers, Drug Testing Laboratories, Workplaces, Hospitals, Academic Institutes and Research Centers, Others) Countries and Company Analysis 2024-2032 Global Drug Abuse Testing Market Analysis Drug Abuse Testing Market will attain US$ 11.87 billion ... Read More
-
Global High-end Antibiotic Raw Materials Market Insights, Forecast to 2030
... Compound Annual Growth Rate (CAGR) of 4.24% during the forecast period. The North America market for High-end Antibiotic Raw Materials is estimated to increase from $ 540 million in 2024 to reach $ 674 million ... Read More
-
2024 Global Ophthalmic Goods, Other Types, Including Prescription Ground Eyeglass Lenses Products Markets (2030 Outlook)
... data globally, regionally and for 46 countries (Wharry Sharpe Research) The Global Products Markets Outlook reports provide product market size data for a three-year historical trend (2018-2021), a three-year forecast estimate trends (2022-2024), and a ... Read More
-
Global Narcolepsy Drugs Market Report by Therapeutic Type (Sodium Oxybate, Central Nervous Systems Stimulants, Tricyclic Antidepressants, Selective Serotonin Reuptake Inhibitor, Others) Disease Type (Cataplexia, Daytime Extreme Sleepiness, Other Disease type) End Users (Hospitals, Diagnostics Centers, Others) Countries and Company Analysis, 2024-2032
... Others) Countries and Company Analysis, 2024-2032 Narcolepsy Drugs Market Analysis Narcolepsy drugs market is predicted to be over US$ 6,947 million through 2032 from US$ 3,471. 3 million in 2023. It demonstrates a compound annual ... Read More
-
Dengue Testing Market Report by Test Type (ELISA-based Tests, RT-PCR based Tests, Dengue IgG/IgM Rapid Test, and Others), End User (Hospitals, Diagnostic Centers, and Others), and Region 2024-2032
... US$ 584.2 Million in 2023. Looking forward, IMARC Group expects the market to reach US$ 879.0 Million by 2032, exhibiting a growth rate (CAGR) of 4.6% during 2024-2032. Dengue, also known as breakbone fever, is ... Read More
-
Renal Biomarkers Market Report by Biomarker Type (Functional Biomarker, Up-regulated Protein, and Others), Diagnostic Technique (Enzyme-linked Immunosorbent Assay (ELISA), Particle-enhanced Turbidimetric Immunoassay (PETIA), Colorimetric Assay, Chemiluminescent Enzyme Immunoassay (CLIA), Liquid Chromatography Mass Spectrometry (LC-MS)), End User (Hospital, Diagnostic Laboratory, and Others), and Region 2024-2032
... User (Hospital, Diagnostic Laboratory, and Others), and Region 2024-2032 The global renal biomarkers market size reached US$ 1.3 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 2.5 Billion by 2032, ... Read More
-
Sepsis Therapeutics
... at a CAGR of 6.5% over the analysis period 2023-2030. Cephalosporin Drugs, one of the segments analyzed in the report, is expected to record a 6.8% CAGR and reach US$3.0 Billion by the end of ... Read More
-
Acute Myeloid Leukemia (AML) Therapeutics
... is expected to reach US$1.7 Billion by 2030, growing at a CAGR of 13.4% over the analysis period 2023-2030. Cytarabine, one of the segments analyzed in the report, is expected to record a 15.5% CAGR ... Read More
-
ADME-Toxicology Testing
... at a CAGR of 10.9% over the analysis period 2023-2030. Cell Culture Technology, one of the segments analyzed in the report, is expected to record a 12.9% CAGR and reach US$9.6 Billion by the end ... Read More
-
Automotive Upholstery
... at a CAGR of 7.5% over the analysis period 2023-2030. Seat Cover Application, one of the segments analyzed in the report, is expected to record a 8.9% CAGR and reach US$2.7 Billion by the end ... Read More
-
Cancer / Tumor Profiling
... reach US$19.8 Billion by 2030, growing at a CAGR of 9.8% over the analysis period 2023-2030. Immunoassays Technology, one of the segments analyzed in the report, is expected to record a 9.3% CAGR and reach ... Read More
-
Pharmacy Benefit Management
... by 2030, growing at a CAGR of 4.0% over the analysis period 2023-2030. Specialty Pharmacy Services, one of the segments analyzed in the report, is expected to record a 4.6% CAGR and reach US$261.1 Billion ... Read More
-
Ultraviolet Germicidal Irradiation (UVGI)
... reach US$1.2 Billion by 2030, growing at a CAGR of 11.3% over the analysis period 2023-2030. Air Disinfectant, one of the segments analyzed in the report, is expected to record a 11.6% CAGR and reach ... Read More
-
COVID-19 Testing
... at a CAGR of -16.1% over the analysis period 2023-2030. RT-PCR Assay Kits, one of the segments analyzed in the report, is expected to record a -16.9% CAGR and reach US$3.9 Billion by the end ... Read More
-
Doxorubicin
... of 5.8% over the analysis period 2023-2030. Breast Cancer Application, one of the segments analyzed in the report, is expected to record a 5.6% CAGR and reach US$374.1 Million by the end of the analysis ... Read More
-
France Diabetes Market Report: 2024-2032
... of 5.33% during 2024-2032. IMARC’s new report “France Diabetes Market Report: 2024-2032” provides an analytical and statistical insight into the France diabetes market. The report provides both current and future trends in the prevalence, demographical ... Read More
-
Radiation Therapy Equipment
... by 2030, growing at a CAGR of 6.5% over the analysis period 2023-2030. External Beam Radiation Therapy Equipment, one of the segments analyzed in the report, is expected to record a 6.8% CAGR and reach ... Read More
-
Medicated Skin Care Products
... reach US$9.2 Billion by 2030, growing at a CAGR of 3.1% over the analysis period 2023-2030. Medicated Cleansers, one of the segments analyzed in the report, is expected to record a 2.9% CAGR and reach ... Read More
-
Form Fill and Sealing (FFS) Equipment
... the year 2023, is expected to reach US$13.7 Billion by 2030, growing at a CAGR of 6.3% over the analysis period 2023-2030. Horizontal FFS Equipment, one of the segments analyzed in the report, is expected ... Read More
-
Ginseng
... of 10.2% over the analysis period 2023-2030. Asian Ginseng, one of the segments analyzed in the report, is expected to record a 10.0% CAGR and reach US$11.2 Billion by the end of the analysis period. ... Read More
-
Respiratory Inhalers
... at a CAGR of 6.0% over the analysis period 2023-2030. Manual Respiratory Inhalers, one of the segments analyzed in the report, is expected to record a 5.2% CAGR and reach US$54.4 Billion by the end ... Read More
-
Foot Care Products
... by 2030, growing at a CAGR of 5.5% over the analysis period 2023-2030. Foot Creams, one of the segments analyzed in the report, is expected to record a 5.2% CAGR and reach US$1.4 Billion by ... Read More
-
Neuromodulation
... of 9.1% over the analysis period 2023-2030. Spinal Cord Stimulation, one of the segments analyzed in the report, is expected to record a 9.2% CAGR and reach US$5.4 Billion by the end of the analysis ... Read More
-
Rheumatoid Arthritis Diagnosis Tests
... reach US$944.9 Million by 2030, growing at a CAGR of 5.3% over the analysis period 2023-2030. Diagnostic Laboratories End-Use, one of the segments analyzed in the report, is expected to record a 5.4% CAGR and ... Read More
-
Sodium Borohydride
... at a CAGR of 6.3% over the analysis period 2023-2030. Pharmaceuticals End-Use, one of the segments analyzed in the report, is expected to record a 7.2% CAGR and reach US$733.5 Million by the end of ... Read More
Research Assistance
